Adc Therapeutics SA

NYSE:ADCT   3:59:59 PM EDT
25.47
-0.12 (-0.47%)
Earnings Announcements

ADC Therapeutics Reports Fourth Quarter And Year-End 2020 Results

Published: 03/18/2021 11:23 GMT
Adc Therapeutics SA (ADCT) - Q4 Diluted Loss per Share 0.73 USD Versus 0.69 USD Loss Year Ago.
Qtrly Net Loss per Share, Basic and Diluted $0.73.
Qtrly Adjusted Net Loss per Share, Basic and Diluted $0.82.
Revenue is expected to be $7.17 Million
Adjusted EPS is expected to be -$0.89

Next Quarter Revenue Guidance is expected to be $10.49 Million
Next Quarter EPS Guidance is expected to be -$0.97

More details on our Analysts Page.